# Nuclide record lutectomy (trial). Data CC BY-NC 4.0, attribute "Data from Nuclide (nuclide.cc)". Whole corpus: https://nuclide.cc/api/v1/nuclide.nt
@prefix schema: <https://schema.org/> .
@prefix nuclide: <https://nuclide.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://nuclide.cc/trials/lutectomy/>
  a schema:MedicalTrial ;
  nuclide:kind "trial" ;
  schema:identifier "lutectomy", "NCT04430192" ;
  schema:name "LuTectomy"@en ;
  schema:alternateName "Neoadjuvant 177Lu-PSMA-617 before radical prostatectomy"@en ;
  schema:description "In men about to have their prostate removed for high-risk cancer, giving one or two doses of the radioactive drug lutetium-PSMA beforehand delivered a meaningful radiation dose straight to the tumour, was well tolerated, and did not make the surgery harder or riskier."@en ;
  schema:url <https://nuclide.cc/trials/lutectomy/> ;
  schema:dateModified "2026-09-22"^^xsd:date ;
  schema:citation <https://pubmed.ncbi.nlm.nih.gov/37891072/>, <https://clinicaltrials.gov/study/NCT04430192> ;
  nuclide:status "active" ;
  nuclide:tag "radioligand therapy", "prostate cancer", "neoadjuvant", "dosimetry" ;
  nuclide:phase "1/2" ;
  nuclide:related <https://nuclide.cc/drugs/pluvicto/>, <https://nuclide.cc/indications/prostate-high-risk/>, <https://nuclide.cc/terms/prostatectomy/>, <https://nuclide.cc/technologies/psma-pet/>, <https://nuclide.cc/isotopes/ga-68/>, <https://nuclide.cc/isotopes/lu-177/> .